BONUSCAP-ZERTIFIKAT - PFIZER INC | Real-time BOERSE MUENCHEN 13:45:20 2024-05-23 EDT | ||
| 36.46 EUR | -2.51% |
|
| Current month | +25.04% | ||
| 1 month | +18.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 36.46 | -2.51% |
| 24-05-22 | 37.4 | +2.38% |
| 24-05-21 | 36.53 | +0.72% |
| 24-05-20 | 36.27 | -0.03% |
| 24-05-17 | 36.28 | -1.52% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 01:45 pm
More quotesStatic data
| Product type | Bonus- and Part-Guarantee-Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
UniCredit
|
| WKN | HD3TXR |
| ISIN | DE000HD3TXR7 |
| Date issued | 2024-03-18 |
| Strike | 44 $ |
| Maturity | 2025-06-20 (393 Days) |
| Parity | 1 : 1 |
| Emission price | 33.59 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 37.75 € |
|---|---|
| Lowest since issue | 29.16 € |
| Spread | 0.01 € |
| Spread % | 0.03% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.6
USD
Average target price
31.94
USD
Spread / Average Target
+7.90%
- Stock Market
- Certificates
- Certificat
